50988-14-2

Basic information

• Product Name: 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol
• Synonyms: 1,2,3,4-Tetrahydro-4,6,7-isoquinolinetriol; 4,6,7-Isoquinolinetriol, 1,2,3,4-tetrahydro-
• CAS NO: 50988-14-2
• Molecular Formula: C₉H₁₁NO₃
• Molecular Weight: 181.1885
• Mol File: 50988-14-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 460.6°C at 760 mmHg
• Flash Point: 252°C
• Density: 1.436g/cm³
• Vapor Pressure: 2.79E-09mmHg at 25°C
• Refractive Index: 1.67
• CAS DataBase Reference: 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol(50988-14-2)
• EPA Substance Registry System: 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol(50988-14-2)

Safety Data

• Hazardous Substances Data: 50988-14-2(Hazardous Substances Data)

Usage

Derivative of tetrahydroisoquinoline

The compound is derived from the tetrahydroisoquinoline structure, which is a type of organic compound with a specific arrangement of atoms.

Presence of four hydroxyl groups

The molecule is characterized by having four hydroxyl (-OH) groups attached to the structure, which contribute to its chemical properties and potential pharmacological activities.

Antioxidant activity

1,2,3,4-tetrahydroisoquinoline-4,6,7-triol has been shown to exhibit antioxidant properties, meaning it can help neutralize harmful free radicals and protect cells from oxidative damage.

Radical scavenging activity

In addition to its antioxidant properties, the compound has also demonstrated the ability to scavenge radicals, which are highly reactive and potentially damaging molecules.

Potential use in the treatment of neurological disorders

Research has investigated the possible applications of 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol in treating neurological conditions, such as Alzheimer's disease, due to its potential pharmacological properties.

Therapeutic agent for conditions like Alzheimer's disease

The compound is being studied as a potential therapeutic agent for Alzheimer's disease, a progressive neurological disorder that affects memory, thinking, and behavior.

Ongoing research

Further studies are being conducted to explore the full range of potential applications and implications of 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol in the fields of medicine and pharmacology, as its complete scope of activity and potential uses are not yet fully understood.